Oricell Therapeutics
Develops next-generation cell therapies for oncology and immunology
$110MPre-IPO
Role not disclosedBM
Beijing Medical and Health Care Industry Investment Fund
Activity from announced rounds
Activity in this selectionApr 30, 2026 · Apr 1, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 0 First participation on record · 1 follow-on
- Funding in participating rounds
- $110M 1 disclosed · full round size, not this investor’s share